Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj
Clinical trial NCT04730024 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04730024
- Sponsor
- Kang Stem Biotech Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-03-27
- Primary completion
- 2030-06-30
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.